News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
693,561 Results
Type
Article (39428)
Company Profile (249)
Press Release (653884)
Section
Business (204049)
Career Advice (2006)
Deals (35408)
Drug Delivery (93)
Drug Development (80965)
Employer Resources (169)
FDA (16138)
Job Trends (14831)
News (344923)
Policy (32479)
Tag
Academia (2538)
Alliances (49331)
Alzheimer's disease (1320)
Approvals (16126)
Artificial intelligence (209)
Bankruptcy (357)
Best Places to Work (11637)
Biotechnology (177)
Breast cancer (231)
Cancer (1779)
Cardiovascular disease (132)
Career advice (1670)
CAR-T (131)
Cell therapy (372)
Clinical research (65362)
Collaboration (693)
Compensation (383)
COVID-19 (2568)
C-suite (174)
Data (1703)
Diabetes (222)
Diagnostics (6300)
Earnings (85678)
Employer resources (145)
Events (111129)
Executive appointments (584)
FDA (17091)
Funding (622)
Gene therapy (255)
GLP-1 (657)
Government (4363)
Healthcare (18783)
Infectious disease (2686)
Interviews (311)
IPO (16467)
Job creations (3627)
Job search strategy (1421)
Layoffs (440)
Legal (7890)
Lung cancer (259)
Manufacturing (243)
Medical device (13281)
Medtech (13286)
Mergers & acquisitions (19337)
Metabolic disorders (573)
Neuroscience (1743)
NextGen: Class of 2025 (6510)
Non-profit (4476)
Northern California (2199)
Obesity (314)
Opinion (196)
Patents (174)
People (56897)
Phase I (20353)
Phase II (28790)
Phase III (21439)
Pipeline (797)
Postmarket research (2563)
Preclinical (8589)
Radiopharmaceuticals (242)
Rare diseases (331)
Real estate (5897)
Regulatory (21985)
Research institute (2314)
Resumes & cover letters (349)
Southern California (1876)
Startups (3569)
United States (19232)
Vaccines (622)
Weight loss (214)
Date
Today (159)
Last 7 days (780)
Last 30 days (2809)
Last 365 days (34348)
2025 (5457)
2024 (35220)
2023 (40076)
2022 (51173)
2021 (55710)
2020 (54083)
2019 (46538)
2018 (35018)
2017 (32109)
2016 (31480)
2015 (37552)
2014 (31318)
2013 (26345)
2012 (28570)
2011 (29263)
2010 (27328)
Location
Africa (717)
Arizona (211)
Asia (37551)
Australia (6140)
California (4994)
Canada (1752)
China (412)
Colorado (227)
Connecticut (237)
Europe (80507)
Florida (734)
Georgia (171)
Illinois (464)
Indiana (272)
Japan (126)
Maryland (760)
Massachusetts (3791)
Michigan (200)
Minnesota (345)
New Jersey (1412)
New York (1425)
North Carolina (858)
Northern California (2199)
Ohio (175)
Pennsylvania (1136)
South America (1093)
Southern California (1876)
Texas (727)
Utah (155)
Washington State (476)
693,561 Results for "xyphos inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
PHANES THERAPEUTICS entered into a research collaboration with Xyphos Biosciences, Inc., an Astellas Company
Phanes Therapeutics, Inc. today announced that it has entered into a research collaboration with Xyphos Biosciences, Inc. an Astellas Company.
March 6, 2023
·
2 min read
Business
Astellas and Poseida Therapeutics Enter Into Research Collaboration and License Agreement to Develop Novel Allogeneic Cell Therapies in Oncology
Astellas Pharma Inc. and Poseida Therapeutics, Inc. today announced that Xyphos Biosciences, Inc., (a wholly owned subsidiary of Astellas, “Xyphos”) and Poseida have entered into a research collaboration and license agreement to develop novel convertibleCAR® programs by combining the innovative cell therapy platforms from each of the companies.
May 1, 2024
·
8 min read
Genetown
Astellas and Kelonia Therapeutics Enter into Research and License Agreement to Develop Novel Immuno-Oncology Therapeutics
Astellas Pharma Inc. and Kelonia Therapeutics announced that Xyphos Biosciences, Inc., and Kelonia have entered into a research collaboration and license agreement to develop novel Immuno-Oncology therapeutics.
February 15, 2024
·
6 min read
Press Releases
electroCore, Inc. Announces Agreement with Spark Biomedical Inc. to Distribute Sparrow Ascent for Opioid Withdrawal
February 27, 2025
·
4 min read
Press Releases
Moss Genomics Inc. Announces Leadership Changes
February 26, 2025
·
5 min read
Press Releases
Albertsons Companies, Inc. Announces CEO Succession Plan
March 3, 2025
·
8 min read
Business
Phenomic Enters into Strategic Research Collaboration with Astellas for Solid Tumor Cell Therapies
Phenomic AI Inc. (“Phenomic”), a biotech company developing therapies for stroma-rich tumors using its scTx® single cell transcriptomics platform, has entered into a strategic research collaboration with Astellas Pharma Inc., “Astellas” through Xyphos Biosciences, Inc. (a wholly owned subsidiary of Astellas).
November 30, 2023
·
2 min read
Press Releases
Bolt Biotherapeutics, Inc. Provides Update on Global Cancer Immunotherapy Co-Development with Toray Industries, Inc.
February 12, 2025
·
6 min read
Press Releases
Exicure, Inc. Announces Purchase Agreement with GPCR Therapeutics Inc.
January 23, 2025
·
5 min read
Press Releases
HOPE Therapeutics™, Inc. and NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Engage BTIG as Financial Advisor
February 3, 2025
·
7 min read
1 of 69,357
Next
